Association of BNT162b2 Vaccine Third Dose Receipt With Incidence of SARS-CoV-2 Infection, COVID-19–Related Hospitalization, and Death Among Residents of Long-term Care Facilities, August to October 2021

IMPORTANCE: COVID-19 vaccine might be less immunogenic and effective among residents of long-term care facilities (LTCFs). OBJECTIVE: To examine the association of BNT162b2 third dose (first booster dose) with overall SARS-CoV-2 infection, COVID-19 hospitalizations, and mortality among LTCF resident...

Descripción completa

Detalles Bibliográficos
Autores principales: Muhsen, Khitam, Maimon, Nimrod, Mizrahi, Amiel Yaron, Varticovschi, Baruch, Bodenheimer, Omri, Cohen, Dani, Dagan, Ron
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250055/
https://www.ncbi.nlm.nih.gov/pubmed/35796153
http://dx.doi.org/10.1001/jamanetworkopen.2022.19940

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9250055/
https://www.ncbi.nlm.nih.gov/pubmed/35796153
http://dx.doi.org/10.1001/jamanetworkopen.2022.19940

Ejemplares similares